The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
LARIMAR THERAPEUTICS INC | COM | 517125100 | 1,762,277 | 232,184 | SH | SOLE | 232,184 | 0 | 0 | |||
SNAP INC | CL A | 83304A106 | 2,819,017 | 245,559 | SH | SOLE | 0 | 0 | 245,559 | |||
ROKU INC | COM CL A | 77543R102 | 3,760,765 | 57,707 | SH | SOLE | 57,707 | 0 | 0 | |||
DRAFTKINGS INC | COM CL A | 26142V105 | 267,665,113 | 5,894,409 | SH | SOLE | 5,894,409 | 0 | 0 | |||
INTEGRAL AD SCIENCE HLDNG CO | COM | 45828L108 | 226,546,017 | 22,722,770 | SH | SOLE | 22,722,770 | 0 | 0 |